E
Ember LifeSciences
A global temperature control brand and technology platform that pioneered the world's first temperature control mug
About Ember LifeSciences
Ember Life Sciences specializes in advanced temperature control solutions, focusing on reducing waste in pharmaceutical shipping. The company operates in the global logistics and healthcare markets, providing innovative products like the Ember Cube. This cloud-based SaaS dashboard integrates cellular radio and GPS to offer real-time location, temperature, and humidity tracking. The Ember Cube's return-to-sender feature significantly cuts down on shipping waste by replacing single-use materials such as Styrofoam, ice packs, and cardboard. Ember Life Sciences serves pharmaceutical companies and logistics providers, offering a subscription-based business model that generates revenue through recurring fees for its technology platform and services. The company's mission is to revolutionize the way temperature-sensitive products are shipped, ensuring precision, control, and accuracy.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jul 2026 | $0 | — | Alfresa | ↗ |
| SERIES A✓Equity / VC | Dec 2025 | $27M | $108M | TDF Ventures · Amgen Ventures | ↗ |
Growth signals
Latest recorded traffic for Ember LifeSciences is 3.4K monthly website visits, up 88.9% over the last three months.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- CVCarrier Ventures
TDF Ventures
Amgen Ventures
Alfresa
Other known investors2 additional known investors
Cardinal Health
Gozde Tech Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ember LifeSciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ember LifeSciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







